Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors.
Saved in:
| Title: | Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. |
|---|---|
| Authors: | Rodriguez GI; Cancer Therapy and Research Center, San Antonio, Texas 78207, USA. grodrigu@saci.org, Jones RE, Orenberg EK, Stoltz ML, Brooks DJ |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2002 Sep; Vol. 8 (9), pp. 2828-34. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 12231523 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink>; Cancer Therapy and Research Center, San Antonio, Texas 78207, USA. grodrigu@saci.org<br /><searchLink fieldCode="AU" term="%22Jones+RE%22">Jones RE</searchLink><br /><searchLink fieldCode="AU" term="%22Orenberg+EK%22">Orenberg EK</searchLink><br /><searchLink fieldCode="AU" term="%22Stoltz+ML%22">Stoltz ML</searchLink><br /><searchLink fieldCode="AU" term="%22Brooks+DJ%22">Brooks DJ</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2002 Sep; Vol. 8 (9), pp. 2828-34. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1078-0432 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=12231523 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2828 Titles: – TitleFull: Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rodriguez GI – PersonEntity: Name: NameFull: Jones RE – PersonEntity: Name: NameFull: Orenberg EK – PersonEntity: Name: NameFull: Stoltz ML – PersonEntity: Name: NameFull: Brooks DJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2002 Sep Type: published Y: 2002 Identifiers: – Type: issn-print Value: 1078-0432 Numbering: – Type: volume Value: 8 – Type: issue Value: 9 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |
